Friday, 13 June 2014

Insulin Market Expected to Reach USD 32,346.7 Million in 2018 - Transparency Market Research

00:03 No comments
Insulin Market
According to a new market report published by Transparency Market Research "Insulin Market - Global and China Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 - 2018" the global insulin market was worth USD 12,476.3 million in 2011 and is expected to reach USD 32,346.7 million in 2018, growing at a CAGR of 12% from 2011 to 2018. In the global market, China is expected to increase its share in the global insulin market to 10.2% by 2018.
The global insulin market is driven by rise in diabetic population worldwide. The world diabetes population was estimated at 366 million in the year 2011, and is expected to reach 552 million in 2030. It is estimated that diabetes accounts for 4.6 million deaths, with cases of people dying due to lack of insulin and not even being diagnosed.

This however, presents a huge supply demand deficit for insulin, with high growth potential in developing markets. The factors contributing to the insulin market growth also includes increase in global expenditure on healthcare, strong distribution network, and high scope in developing economies such as China and India.

Browse the full Insulin Market Report at http://www.transparencymarketresearch.com/insulin-market.html

It is estimated that worldwide, by year 2030, one in ten people will suffer from diabetes, giving rise to huge demand for insulin. China, being the most populous nation in the world, accounts for the largest share of the global diabetic population and eventually turns out as the most lucrative market for insulin manufacturers.

Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=259

The China insulin market is projected to grow at a CAGR twice that of the global insulin market. It was estimated at USD 723.8 million in 2011, and is projected to reach USD 3,299.1 million in the year 2018, growing at a CAGR of 24.6%. Currently, China accounts for 6.1% of the global insulin market in terms of volume, which was estimated at 22.4 tMU in 2011. The global insulin market by volume is projected to grow at a CAGR of 7.9% from 2012 - 2018.

Browse Blog http://tmrresearch.wordpress.com/

The global insulin market has continuously witnessed new advanced product types being introduced in the market by insulin manufacturers. The recent product type is modern insulin, which is a genetically engineered version of human insulin, and has been selectively modified to counter the issues associated with human insulin. Currently, modern insulin accounts for more than 76% of the global insulin market.
To meet the rising demand, global insulin manufacturers are not only augmenting existing production facilities, but also expanding their global presence to meet the supply demand gap. Leading insulin manufacturers are now focusing on reinforcing their market leadership in China. It includes key global and China insulin market players such as Novo Nordisk, Sanofi-Aventis, and Eli-Lilly. Together they account for more than 90% of the global insulin market share.

Browse all Pharmaceutical Research Report at http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html


This research is specially designed to estimate and analyze the demand and performance of the global and China insulin market in the current market scenario. This research provides in-depth analysis of insulin manufacturers, product sales, trend analysis by segments, and demand by geography. The report covers all the major product segments of the global and China insulin market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. 

Download PDF at Insulin Market - Global And China Industry Analysis, Size, Share, Growth, And Forecast 2011 - 2018
Read More

Thursday, 12 June 2014

Membrane Separation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

01:26 No comments
According to a new market report published by Transparency Market Research "Membrane separation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global membrane separation market was valued at USD 19.0 billion in 2012 and is expected to grow at a CAGR of 10.8% from 2013 to 2019, to reach an estimated value of USD 39.2 billion in 2019.

Browse the full Membrane separation Market Report at http://www.transparencymarketresearch.com/membrane-separation-market.html

The increasing demand for clean processed water and mandatory government regulation to provide clean drinking water is propelling the water processing industry at present. Membrane separation is one of the most popular methods used for cleaning water. Shifting from chemical to physical treatments of water is also a major driver as chemical treatments are perceived as an environmentally unclean technology with associated disposal costs. Additional awareness of water scarcity has influenced the demand for water reuse in water stressed areas. Governments and municipal authorities are increasingly waking up to the effects of environmental degradation on the economy. Mandatory adherence of certain environmental standards by the national government such as the Clean Water Act especially in areas with water scarcity have influenced the demand for better water treatment technology, including membrane separation technology.


Worldwide industrial expansion and growing population are propelling the demand for better water treatment technology, providing growth opportunity for the overall market of membrane separation technology. Additionally, the oil and petroleum industry is well established in countries such as Italy and Germany which involve membrane separation technology for liquid separation. Membrane separation technology is majorly divided under four major processes, microfiltration, ultrafiltration, nanofiltration and reverse osmosis. Microfiltration dominates the market with more than 35% global market share. Whereas water & wastewater dominates the end-user market with 36% global market shares in terms of uses. The global membrane separation market grew from USD 19.0 billion in 2010 to USD 21.2 billion in 2013.
European membrane market is expected to reach USD 13.8 billion in 2019. In 2012 water & wastewater sector was the major end-user of membrane separation technology and is expected to increase at a CAGR of 11.1% during 2013-19. The membrane separation technology market is fragmented with several players in the market supplying membrane separation to the end-users in the market.


Membrane separation is used by various sectors such as water and wastewater treatment and industrial and healthcare sectors. Most of the companies produce different types of membrane products such as microfiltration, nanofiltration, ultrafiltration and reverse osmosis and sell them globally. Major companies that are operating globally and manufacturing all four products are Koch Membrane Systems Inc., Pall Corporation, Merck Millipore, 3M Company, Degremont SA, Dow Chemical Company, GEA Filtration, Nitto Denko Corporation, Époque Water Technologies and Veolia Environnement.

Read More

Monday, 9 June 2014

Neuromodulation Devices Market growing at a CAGR of 14.4% from 2013 to 2019. By Transparency Market Research

04:50 No comments
Neuromodulation devices market was valued at USD 2,758 million in 2011 and is expected to grow at a CAGR of 14.4% from 2012 to 2018, to reach an estimated value of USD 7,072.6 million by 2018.


The market is driven by factors such as the aging world population leading to chronic diseases such as Parkinson's and Alzheimer's disorders and technological advancements in the field of neuromodulation devices including the invention of transdermal neuromodulation technology by NMT (Neurowave Medical Technologies). Moreover, the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, the availability of external funding to conduct clinical studies to help come up with new and technologically advanced products and the rising healthcare related consumer expenditure have also driven the growth in this market. The fact that a neuromodulation device could be used as an add-on treatment and so can be used simultaneously with other medications also drives the market forward.

The North American region holds majority of the market share and accounted for a share of 65% in 2011. The North Americanneuromodulation device market was valued at USD 1,792.7 million in 2011. The economic developments in the Asia Pacificregion make it the fastest growing region (CAGR of more than 15% from 2012 to 2018) in the neuromodulation devices market.

The future growth of the market will be ensured by capitalizing on market opportunities such as increasing healthcare related consumer expenditure in emerging economies in the Asia Pacific, Latin American and Eastern European regions. The availability of medical device manufacturing outsourcing options helps in curbing costs and thereby enhances profit margins. Also, the presence of consolidation options in the healthcare industry helps in strengthening the revenue base to conduct R&D exercises for new product development and thus helps in strengthening market share.

Implementation of the Affordable Healthcare for America Act, 2010 which imposes an excise tax of 2.5% on medical devices and the stringent FDA regulations are some of the factors restraining the growth of the market. Risks involved in using a neuromodulation device such as injury to the vagus nerve and nearby blood vessels (carotid artery and jugular vein) in case of a vagus nerve pacemaker also impedes the growth of the market.
·         Neuromodulation Devices Market by Technology
o    Spinal Cord Stimulation Devices
o    Deep Brain Stimulation Devices
o    Vagus Nerve Stimulation Devices
o    Sacral Nerve Stimulation Devices
o    Gastric Electric Stimulation Devices
·         Neuromodulation Systems for Different Application Areas
o    Medtronic's Spinal Cord and Deep Brain Neurostimulation Systems
o    St. Jude Medical's Eon  Mini Neurostimulator System
o    Boston Scientific's Precision Spinal Cord Stimulation System
o    Nevro's Senza System for Spinal Cord Stimulation
o    Cyberonics' VNS Therapy System
o    Codman & Shurtleff's Medstream system
o    Medtronic's Enterra™ Therapy System
o    IntraPace's abiliti system
·         Neuromodulation Devices Market by Geography
o    North America
o    Europe
o    Asia Pacific
o    RoW (Rest of the World)


Browse all Pharmaceutical Market Research Reports

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.


Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Read More

Thursday, 5 June 2014

Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

04:09 No comments
Smoking Cessation and Nicotine De-addiction Products Market 
According to a new market report published by Transparency Market Research "Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global smoking cessation and nicotine de-addiction productsmarket was valued at USD 5.1 billion in 2012 and is expected to grow at a CAGR of 18.7% from 2013 to 2019, to reach an estimated value of USD 16.02billion in 2019.

Smoking cessation is a process of discontinuing smoking achieved by the use of medication. It may also be coupled with assistance of healthcare professionals, counselling and psychotherapy. The demand for smoking cessation products is high and is continuously rising as it caters to the needs of people addicted to nicotine and rising healthcare awareness amongst the smokers. The global smoking cessation and nicotine de-addiction products market is segmented on the basis of product types available in the market. These include nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. This market is sustained by large number of people wanting to quit smoking.

Browse Global Smoking Cessation and Nicotine De-addiction Products Market with full TOC at http://www.transparencymarketresearch.com/smoking-cessation-nicotine-de-addiction-products.html

The nicotine patches and lozenges market is driven by its ease of use and non-prescription sale. Nicotine sprays and inhalers on the other hand are less preferred due to their high cost and less popularity. However, increased promotional activities and effective distribution is expected to boost their market growth in the near future. The major players in the NRT products market include Johnson and Johnson, GSK, Cipla and Novartis.
Smoking cessation drug therapy market is expected to witness a decline in revenue across the globe, by the end of the forecast period due to patent expiration of the key revenue generating drugs Zyban (bupropion)  in 2013 and Chantix/Champix (varenicline) in 2018 (which will impede market growth toa lower extent). The loss of patent and marketing exclusivity will lead to a drastic reduction in revenue and in turn provide an opportunity to generic manufacturers to launch their own versions of these brands. The leading players in the drug therapy market are GSK and Pfizer.


Geographically, North America dominates the global smoking cessation and nicotine de-addiction products market. The North American market for smoking cessation products was valued at USD 1,958.8 million in the year 2012. An increase in cigarette costs is expected to reduce smoking rates significantly, especially in adolescents. According to the CDC, a 10% rise in cigarettes cost can cut around 4% of young adults craving cigarette consumption. The European market held the second largest share worldwide, in 2012. WHO reports that European countries have widely adopted bans on tobacco advertising, promotion on national/international television and radio, billboards and outdoor advertising, local magazines and newspapers. However, some countries in Europe still lack in implementing measures of the WHO Framework Convention on Tobacco Control (FCTC).


Raising taxes to increase the cost of cigarettes can reduce tobacco use, cut smoking rates, and ultimately save lives. Smoking prevalence has been varying across the globe with many developing countries witnessing rapid increase in the prevalence rate, which will create huge health problems for the future if left unchecked. Demand for lifestyle drugs in emerging countries is witnessing rapid growth due to factors including growing health awareness, increase in population, and development of public healthcare systems, among others. This is driving people towards quitting smoking by adopting smoking cessation products. A study in the Eastern Mediterranean Health Journal, published in 2012, reported that nicotine containing medications are not available in one third of the developing countries, which include the Middle East and Africa. Moreover, accessibility of non-nicotine containing medications such as bupropion and varenicline is also extremely low. Increased attention and resources are needed to address lack of smoking cessation services as well as access to nicotine containing medications in these regions.

Read More

Wednesday, 28 May 2014

Narcolepsy Market - Global Industry Analysis, Size, Trends And Forecast, 2013 – 2019

02:48 No comments
Transparency Market Research Reports incorporated a definite business overview and investigation inclines on "Narcolepsy Marke ". This report likewise incorporates more illumination about fundamental review of the business including definitions, requisitions and worldwide business sector industry structure. Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors.

Browse Full Report with TOC:
http://www.transparencymarketresearch.com/narcolepsy-market.html

Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is often confused with insomnia. Other major symptoms of this disorder include, cataplexy, sleep paralysis, hypnagogic hallucinations, automatic behavior and night weakness.

Some of the major factors driving the growth of this market include increasing prevalence of various sleep disorders including narcolepsy, rising awareness about the disorder and increasing demand for advanced therapeutics and diagnostics.Narcoleptic disorder is equally prevalent to Parkinson’s disease or multiple sclerosis and is more prevalent than cystic fibrosis. There are more than 3 million people suffering from this disorder worldwide.Rising awareness about the disorder, and the resultant increase in demand for new and innovative drugs and other treatment optionswill lead to the growth of this market in future.

Geographically, North America dominates the global narcolepsy market followed by Europe. Major factors responsible for their dominance are high prevalence rate of narcolepsy in these regions. U.S. alone accounts for more than 200,000 narcoleptic individuals and is also characterized by high awareness levels among the general population. Asia-Pacific region exhibited fastest growth in this market due to increasing awareness levels about the disease and its treatment options and increasing spending power of the population. 

Some of the key players operating in this market are Addrenex Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Cephalon, Inc., Evotec AG, Graymark Healthcare, Inc., Hypnion, Inc., Jazz Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America
  • Asia Pacific
  • Europe
  • Rest of the World 
This report provides comprehensive analysis of 

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

More Reports on Pharmaceutical Market: 
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Browse Market Research Report:-
http://www.tmrblog.com/

http://marketingfirmblog.wordpress.com/

About Us:-

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

Contact Us

Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Read More

Wednesday, 2 April 2014

Organ Preservation Solutions Market predicted to reach USD 204.9 Million Globally in the Forecast 2013 – 2019: Transparency Market Research

05:02 No comments
Transparency Market Research, In Its Latest Report Projects that the Market for Organ Preservation Solutions will post a 16.5% CAGR through 2019


Transparency Market Research announced its new report on the Organ Preservation Solutions market that was first valued at USD 0.06 billion in 2012. However, the current market value is predicted to reach USD 204.9 million by 2019 at a CAGR growth rate of 16.5% for the market revenue forecast period 2013 to 2019.

An organ preservation solution is a method of preserving the organs of the body when they are not inside the body system. It is a medically proven technique of letting the organs become vulnerable to the exterior environment outside the human body. Hence, the organs that are removed from the human body are then preserved in specific adjustments using medical solutions. Organ preservation solutions have been playing a key role in increasing the number of organ transplants. They are intended for different purposes such as organ development of biologics and drugs, and organ transplant procedures and research.

Today, the medical industry has a growing demand for organ transplants in forms of different organ types including liver and kidney too. Such aspects are likely to infuse significant demand for organ preservation solutions in the long run.

The global market for organ preservation solutions has been predicted to grow at a CAGR rate of 16.5% during the forecast period 2013 to 2019. Moreover, it is projected to reach market revenue of USD 204.9 Million in the same forecast period. The Organ preservation solutions report studies the deep insights of this market and foresights every major solution for preserving organs. Amongst the proposed solutions, Viaspan and Custodiol are together accounted for over 75% of the total market share. During this market forecast period 2013 to 2019, the Custodiol market is predicted to rise and grow at a CAGR of 17.1%. 

The organ preservation solutions market is primarily driven by the rising incidences of organ failures in the patients due to changes in lifestyles such as fast food consumption, smoking, and alcohol, and increasing number of patients who are eagerly waiting to get an organ transplant done. The market also gets its popularity due to the rise in geriatric population, particularly in the developed regions such as U.K and U.S. All these conditions and locales are likely to propel the growth of this specific market. Another major reason for this growing sector is the rise in per capita healthcare expense and the advancing imbursement setups arranged for the organ transplant procedures in nations such as U.K, U.S., as well as now in India too.

Additionally, there are interesting techniques which are implemented to preserve the organs in the appropriate spaces. These include hypothermic perfusion preservation (HPP), static cold storage (SCS), and many others. Organ preservation solutions is extensively utilized for preserving different organs such as liver and kidney as it is highly capable of preserving a variety of organs unlike solutions such as HBS and Perfadex solution. 

Unlike the SCS that does not allow any continuous contact of the organ with solution, the HPP is a much better and adaptable technique to use. It is a machine perfusion process that maintains a constant supply to the organs needed by the solution whereby, the survival duration of the organs increases accordingly. The HPP market is anticipated to grow at a CAGR of 19.2% during the forecast period 2013 to 2019.

Earlier, in 2012, the European region had been accounted for the largest share of market revenue and until the present times, it still continues to prove its growth with a rate of 49.96% for 2012 (%). This is due to the presence of a large number of voluntary organ donors in this region. Nevertheless, other countries such as North America (42.23%), Asia-Pacific (5.66%), and RoW (2.15%) help propel the growth of the organ preservation solutions market as well.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Read More

Tuesday, 1 April 2014

Life Sciences BPO Market Projected to Grow at a CAGR of 21.5% between 2013 and 2019

04:06 No comments

As the life sciences industry becomes increasingly competitive while being pressured by regulatory mandates, business process outsourcing (BPO) is being considered as an effective way to improve operational performance.

Source : http://www.transparencymarketresearch.com/life-sciences-bpo-market.html

The market for life sciences BPO is comprised of two distinct entities offering their services to biotech and pharmaceutical companies—Contract Research Organizations and Contract Manufacturing Organizations.

But what are the factors that have given rise to a demand for life science BPO services? The pharma industry is constantly grappling with patent expirations, a pressure to develop low-cost drugs, and the growing uncertainty in economic conditions. Companies in this domain thus need to approach their core operations with singular focus. This is where life science BPO enterprises come into the picture with their support services. Pharma companies outsource various functions and non-core operations to third parties with a view to streamlining their value chain and cutting costs.

These partnerships are usually forged in the form of long-term contracts and partnerships with CMOs and CROs. Through these partnerships, pharma companies share costs right from drug discovery and development to licensing to approvals with the CMOs and/or CROs.

Pharma companies are also experiencing effective outcomes via life science BPOs; the latter leverage their experience, trained professionals, and latest technology to the advantage of the former.

On the other hand, life-science BPOs too have been driven by the pressure to compete and achieve profitability. They try to accomplish this by introducing novel strategies to offer their clients a competitive advantage. According to a market research report published by U.S.-based market research firm Transparency Market Research, the global life sciences BPO market is projected to record a compounded annual growth rate (CAGR) of 21.5% between 2013 and 2019. 

Experts predict a healthy growth rate thanks to factors such as increased R&D investments by pharmaceutical companies, a spike in the demand for generic drugs, as well as a myriad of block buster drugs nearing the end of their patents. Other factors that have created a favorable environment for life science BPO include stringent regulatory mandates and government pressure to develop affordable drugs.

The Contract Manufacturing Organizations Market

According to the market research report published by Transparency Market Research, the CMO life science services outsourcing currently holds the largest share in the Life Sciences BPO market. The growth in healthcare costs has subsequently caused an increased generic drug demand, which has in turn led to a spike in the demand for the services of pharmaceutical outsourcing enterprises. Moreover, most CMOs have full-fledged R&D centers that employ novel technologies to give their clients an edge.

The market for active pharmaceutical ingredients (API) is the largest within the CMO segment. With mounting regulatory compliance and stringent approval parameters, the outsourcing of manufacturing activities to CMOs has received a boost.

At a time when manufacturers are striving to stay abreast of the latest regulatory mandates and industry breakthroughs, continually investing in facility upgrades might not be possible. This is another factor that can be attributed to the surge in demand for outsourcing partners as manufacturers do not possesses every required technology or expertise in-house. In such scenarios, outsourcing not only gives them access to the latest manufacturing technologies, but also proves to be a cost effective strategy.

The Contract Research Organizations (CRO) Market

Over the past decade, there has been considerable growth in the outsourcing services offered by CROs. Many pharmaceutical companies have been struggling to find a balance between mounting research costs and profitability. This has led many of these firms to turn towards CROs as a feasible option. The vendors operating in the market currently offer a combination of various services such as research, regulatory co-ordination services, data management, website management, medical writing, protocol development and others.

In 2012, the largest segment within this market was drug discovery. A report by Transparency Market Research however projects that between 2013 and 2019, the highest growth will be seen in the clinical data management BPO services at the rate of 17.3%.
Growth Projections

It is estimated that the Life Sciences BPO Market will be worth USD 596 billion worldwide by 2019, according to the Transparency Market Research report. And, while North America held the largest share in this market in 2012 with a worth of USD 28.4 billion, future growth is expected to be the highest in the Asia Pacific region with an approximate growth rate of 21.2% driven by various factors such as low cost of labor, availability of a talent pool, a large patient population, and comparatively favorable regulatory policies. 

Read More
Subscribe to: Posts (Atom)